Mutares Clears Covenant Deadline, Pinning Its Twin Ambitions on a Magirus Exit
30.06.2026 - 13:25:54 | boerse-global.de
Mutares has navigated a critical compliance test, but the relief may be short-lived as the company’s broader financial strategy now hinges on a single high-stakes divestiture. The Munich-based holding company faced a June 29 deadline to prove its net-debt-to-equity ratio had returned to within covenant limits after a breach at the end of 2025. Creditors had suspended checks pending that date, and management expects to confirm compliance following the acquisition of Wärtsilä’s gas-solutions business, which closed on June 1. That bolt-on deal strengthened the balance sheet just in time, with the larger SABIC acquisition still scheduled for the second half of the year.
The immediate pressure from the covenant test has lifted, but the capital demands remain acute. Mutares is simultaneously racing to shrink its bond pile from €385 million to a maximum of €300 million by year-end, aided by quarterly buybacks of at least €25 million starting in the second quarter. Additional liquidity is expected from the sale of NEM Energy Group to Hyundai Heavy Industries, a transaction slated to close in the third quarter pending regulatory clearance. The twin goals of debt reduction and aggressive expansion in the United States require fresh cash, and management has identified one primary source: an exit from Magirus.
Magirus, a firefighting and defense vehicle unit, is at the center of Mutares’ strategic planning. The company is weighing a sale or an initial public offering, though no decision has been announced. The subsidiary’s operating turnaround provides a strong bargaining chip: first-quarter revenue reached roughly €85 million, the order backlog swelled to over €880 million, and the operating loss narrowed sharply from €40 million to €12 million as revenue climbed. A late-2025 acquisition of Achleitner, now rebranded as Magirus Defense Systems, has opened a new growth avenue in armored vehicles, with an initial large order already secured. A successful exit could unlock enough capital to fund both bond buybacks and the U.S. shopping spree, where Mutares has identified a €4.8 billion pipeline of potential acquisition targets.
Should investors sell immediately? Or is it worth buying Mutares?
The U.S. expansion already has a head start thanks to a €105 million capital raise in the spring, but the full spree depends on Magirus proceeds. Mutares needs to beat last year’s gross exit proceeds of roughly €230 million to comfortably cover debt reduction, a potential special dividend, and the transatlantic push. If the Magirus deal falls short, management will face tough trade-offs, and the ambitious U.S. plans could stall.
The upcoming annual general meeting on July 3 will force a reckoning. The board has proposed a base dividend of €2.00 per share, which at the current price of €28.50 equates to a yield of around 7%. But the prospect of a performance dividend—which would only be paid after future exits—has become a bone of contention. Some shareholders are demanding to know why previous divestitures have not already triggered such a payout. The management will have to defend its strategy of preserving cash for bond reduction and expansion before rewarding owners with a one-off distribution.
Operationally, the group reported a 10% revenue rise to nearly €1.7 billion in the first quarter, with adjusted operating profit swinging to €11.1 million. The full-year profit target remains at €165 million, a level that looks attainable only if the anticipated exits materialize on schedule. The stock, currently trading at €28.50, sits just below its 200-day moving average of €28.94, reflecting lingering uncertainty. A London Investor Day in November is expected to provide greater detail on the U.S. strategy, but for now all eyes are on Magirus. The covenant crisis has passed, yet the real test—whether one deal can serve two masters—is just beginning.
Ad
Mutares Stock: New Analysis - 30 June
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
